Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial (Q37278379)

19 August 2017

Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial (English)

1 reference

19 August 2017

phase III clinical trial

0 references

0 references

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Terri S Armstrong

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Minesh Mehta

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Mark R Gilbert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Meihua Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Kenneth D Aldape

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Roger Stupp

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Kurt A Jaeckle

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Jeffrey S Wefel

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Minhee Won

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Deborah T Blumenthal

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Anita Mahajan

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Christopher J Schultz

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Sara Erridge

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Brigitta Baumert

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Kristen I Hopkins

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Tzahala Tzuk-Shina

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Paul D Brown

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Arnab Chakravarti

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Walter J Curran

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

English

0 references

publication date

7 October 2013

1 reference

Journal of Clinical Oncology

19 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

4085-4091

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab

1 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816958

Pseudoprogression following chemoradiotherapy for glioblastoma multiforme.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816958

New (alternative) temozolomide regimens for the treatment of glioma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816958

Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in glioma.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816958

Targeted modulation of MGMT: clinical implications

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816958

MGMT gene silencing and benefit from temozolomide in glioblastoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816958

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816958

Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816958

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816958

Evaluation of survival data and two new rank order statistics arising in its consideration

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816958

The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816958

The randomization and stratification of patients to clinical trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816958

Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816958

Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816958

Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816958

Validation of the M.D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT).

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816958

Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816958

Response criteria for phase II studies of supratentorial malignant glioma

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816958

Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leu

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3816958

3 December 2018

Identifiers

DOI

10.1200/JCO.2013.49.6968

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

release_5yytax5cdbbdha2v5fccdigmki

1 June 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5yytax5cdbbdha2v5fccdigmki

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24101040%20AND%20SRC:MED&resulttype=core&format=json